Stay updated with breaking news from Development Program In Collaboration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: CureVac / Key word: Study results CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK...
Issuer: CureVac / Key word(s): Study results04.04.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza VaccineDevelopment Program in Collaboration with GSK Seasonal flu vaccine candidate boosted anti...